| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.014 | 0.8 |